SPOTLIGHT -
Adjunctive Atypical Antipsychotics in Major Depressive Disorder: What’s the Impact?
The authors explore adjunctive treatments for MDD and their impact on overall medical costs and health care utilization.
Then and Now: Addressing Comorbid PTSD and MDD
The authors examine recent literature in order to assist psychiatrists in evaluating the findings and determining how to best put research findings into real-world practice.
Augmentation Strategies for Depression
A patient with refractory MDD continued to suffer and feel as though her life was turned upside down, despite treatment. Learn the outcome of the case.
5 Tips to Protect Yourself During the Coronavirus Pandemic
In this video, Samantha Gnanasegaram, MD, a psychiatrist New Hampshire Hospital, Concord, NH, talks about the challengers of being a clinician in the days of the coronavirus pandemic.
Medication-Assisted Treatment on a Budget: Two You Should Know
This CME discusses the opioid-like effects of loperamide and kratom and raises awareness of potential dangers associated with use.
New NDA Submitted: Bysanti to Treat Acute Bipolar I and Schizophrenia
Standing Up Against Hate: Let’s Be Foolish
Presenting Our April Theme: Sleep
The Psychiatric Pipeline in Review: Quarter 1, 2025